Rosario Amato

Prof. Dr. Rosario Amato

Università degli Studi "Magna Graecia" di Catanzaro, Catanzaro, Calabria, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2016 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
CTCristina Talarico
Cristina Talarico
VDVincenzo Dattilo
Vincenzo Dattilo
LDLucia D'Antona
Lucia D'Antona
MMMiranda Menniti
Miranda Menniti
CBCataldo Bianco
Cataldo Bianco
RARosario Amato
Rosario Amato
The serum- and glucocorticoid-regulated kinase (SGK) family consists of three members, SGK1, SGK2 and SGK3, all displaying serine/threonine kinase activity and sharing structural and functional similarities with the AKT family of kinases. SGK1 was originally described as a key enzyme in the hormonal regulation of several ion channels and pumps. Over time, growing and impressive evidence has been accumulated, linking SGK1 to the cell survival, de-differentiation, cell cycle control, regulation of caspases, response to chemical, mechanical and oxidative injury in cancer models as well as to the control of mitotic stability. Much evidence shows that SGK1 is over-expressed in a variety of epithelial tumors. More recently, many contributions to the published literature demonstrate that SGK1 can mediate chemo-and radio-resistance during the treatment of various human tumors, both in vitro and in vivo. SGK1 appears therefore as a dirty player in the stress response to chemical and radio-agents, responsible of a selective advantage that favors the uncontrolled tumor progression and the selection of the most aggressive clones. The purpose of this review is the analysis of the literature describing SGK1 as central node of the cell resistance, and a summary of the possible strategies in the pharmacological targeting of SGK1.

19 February 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
CTCristina Talarico
Cristina Talarico
VDVincenzo Dattilo
Vincenzo Dattilo
LDLucia D’antona
Lucia D’antona
ABAgnese Barone
Agnese Barone
Nicola AmodioNicola Amodio
Nicola Amodio
RARosario Amato
Rosario Amato
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells

12 January 2012 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
CAClaudia Abbruzzese
Claudia Abbruzzese
SMStefano Mattarocci
Stefano Mattarocci
LPLaura Pizzuti
Laura Pizzuti
AMAnna Maria Mileo
Anna Maria Mileo
PVPaolo Visca
Paolo Visca
Marco PaggiMarco Paggi
Marco Paggi
Background: Lung cancer represents the most frequent cause of death for cancer. In non-small cell lung cancer (NSCLC), which accounts for the vast majority of this disease, only early detection and treatment, when possible, may significantly affect patient's prognosis. An important role in NSCLC malignancy is attributed to the signal transduction pathways involving PI3Kinase, with consequent activation of the AKT family factors. The serum and glucocorticoid kinase (SGK) factors, which share high structural and functional homologies with the AKT factors, are a family of ubiquitously expressed serine/threonine kinases under the control of cellular stress and hormones. SGK1 is the most represented SGK member. Methods: By means of immunohistochemistry and quantitative real-time PCR, we determined SGK1 protein and mRNA expression in a cohort of 66 formalin-fixed, paraffin-embedded NSCLC surgical samples. All samples belonged to patients with a well-documented clinical history. Results: mRNA expression was significantly higher in squamous cell carcinomas, and correlated with several clinical prognostic indicators, being elevated in high-grade tumors and in tumors with bigger size and worse clinical stage. No correlation was found between SGK1 protein expression and these clinical parameters. Conclusions: This explorative analysis of SGK1 expression in NSCLC samples highlights the potential role of this factor in NSCLC patients' prognosis. Moreover, the higher expression in the squamous cell carcinoma subtype opens new therapeutic possibilities in this NSCLC subtype by designing specific kinase inhibitors.

8 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
CTCristina Talarico
Cristina Talarico
LDLucia D’antona
Lucia D’antona
Domenica ScumaciDomenica Scumaci
Domenica Scumaci
ABAgnese Barone
Agnese Barone
FGFrancesco Gigliotti
Francesco Gigliotti
RARosario Amato
Rosario Amato
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy

18 January 2024 in APMIS
Verified
Journal Article
Open access
CBCarolina Brescia
Carolina Brescia
SASalvatore Audia
Salvatore Audia
APAlessia Pugliano
Alessia Pugliano
FSFederica Scaglione
Federica Scaglione
RIRodolfo Iuliano
Rodolfo Iuliano
RARosario Amato
Rosario Amato
The CD4+ T‐cell population plays a vital role in the adaptive immune system by coordinating the immune response against different pathogens. A significant transformation occurs in CD4+ cells during an immune response, as they shift from a dormant state to an active state. This transformation leads to extensive proliferation, differentiation, and cytokine production, which contribute to regulating and coordinating the immune response. Th17 and Treg cells are among the most intriguing CD4+ T‐cell subpopulations in terms of genetics and metabolism. Gene expression modulation processes rely on and are linked to metabolic changes in cells. Lactylation is a new model that combines metabolism and gene modulation to drive Th17/Treg differentiation and functional processes. The focus of this review is on the metabolic pathways that impact lymphocyte gene modulation in a functionally relevant manner.

30 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VDVincenzo Dattilo
Vincenzo Dattilo
LDLucia D’aNtona
Lucia D’aNtona
CTCristina Talarico
Cristina Talarico
MCMjriam Capula
Mjriam Capula
GCGiada Catalogna
Giada Catalogna
RARosario Amato
Rosario Amato
The serum- and glucocorticoid-regulated kinase (SGK1) controls cell transformation and tumor progression. SGK1 affects mitotic stability by regulating the expression of RANBP1/RAN. Here, we demonstrate that SGK1 fluctuations indirectly modify the maturation of pre-miRNAs, by modulating the equilibrium of the RAN/RANBP1/RANGAP1 axis, the main regulator of nucleo-cytoplasmic transport. The levels of pre-miRNAs and mature miRNAs were assessed by qRT-PCR, in total extracts and after differential nuclear/cytoplasmic extraction. RANBP1 expression is the limiting step in the regulation of SGK1-SP1 dependent nuclear export. These results were validated in unrelated tumor models and primary human fibroblasts and corroborated in tumor-engrafted nude mice. The levels of pri-miRNAs, DROSHA, DICER and the compartmental distribution of XPO5 were documented. Experiments using RANGTP conformational antibodies confirmed that SGK1, through RANBP1, decreases the level of the GTP-bound state of RAN. This novel mechanism may play a role in the epigenomic regulation of cell physiology and fate.